Literature DB >> 10484461

Effects of reactive oxygen and nitrogen metabolites on MCP-1-induced monocyte chemotactic activity in vitro.

E Sato1, K L Simpson, M B Grisham, S Koyama, R A Robbins.   

Abstract

Peroxynitrite, an oxidant generated by the interaction between superoxide and nitric oxide (NO), can nitrate tyrosine residues, resulting in compromised protein function. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that attracts monocytes and has a tyrosine residue critical for function. We hypothesized that peroxynitrite would alter MCP-1 activity. Peroxynitrite attenuated MCP-1-induced monocyte chemotactic activity (MCA) in a dose-dependent manner (P < 0.05) but did not attenuate leukotriene B4 or complement-activated serum MCA. The reducing agents dithionite, deferoxamine, and dithiothreitol reversed the MCA inhibition by peroxynitrite, and exogenous L-tyrosine abrogated the inhibition by peroxynitrite. PAPA-NONOate, an NO donor, or superoxide generated by xanthine and xanthine oxidase did not show an inhibitory effect on MCA induced by MCP-1. The peroxynitrite generator 3-morpholinosydnonimine caused a concentration-dependent inhibition of MCA by MCP-1. Peroxynitrite reduced MCP-1 binding to monocytes and resulted in nitrotyrosine formation. These findings are consistent with nitration of tyrosine by peroxynitrite, with subsequent inhibition of MCP-1 binding to monocytes, and suggest that peroxynitrite may play a role in regulation of MCP-1-induced monocyte chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484461     DOI: 10.1152/ajplung.1999.277.3.L543

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  The unique structural and functional features of CXCL12.

Authors:  Rik Janssens; Sofie Struyf; Paul Proost
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

Review 2.  The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.

Authors:  Brooke L Farrugia; Megan S Lord; James Melrose; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 3.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

4.  Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related.

Authors:  M Reale; C Di Giulio; M Cacchio; R C Barbacane; A Grilli; M Felaco; G Bianchi; M Di Gioacchino; P Conti
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 5.  Macrophages as regulators of tumour immunity and immunotherapy.

Authors:  David G DeNardo; Brian Ruffell
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

Review 6.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 7.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

8.  CCL2 nitration is a negative regulator of chemokine-mediated inflammation.

Authors:  Catriona E Barker; Sarah Thompson; Graeme O'Boyle; Hugues Lortat-Jacob; Neil S Sheerin; Simi Ali; John A Kirby
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 9.  Transplantation and inflammation: implications for the modification of chemokine function.

Authors:  Catriona E Barker; Simi Ali; Graeme O'Boyle; John A Kirby
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

10.  Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.

Authors:  Rik Janssens; Anneleen Mortier; Daiane Boff; Vincent Vanheule; Mieke Gouwy; Charlotte Franck; Olav Larsen; Mette M Rosenkilde; Jo Van Damme; Flávio A Amaral; Mauro M Teixeira; Sofie Struyf; Paul Proost
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.